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1. Introduction 
In the life sciences, scientists are paying more and more attention to the human brain, the 
essential center of the body. The gliomas in human brains are especially unique challenges 
for doctors due to the difficulties of identifying early cancer lesions and little effective 
treatments. Gliomas account for about half of the central nervous system tumors. Due to its 
invasive growth and other malignant behaviors, gliomas are difficult to be radically cured; 
moreover, most of gliomas are difficult to be early detected, even they are discovered, it is 
difficult to cure them because of their resistance to radiation or chemotherapy. Therefore, 
developing animal models of human gliomas is essential for us to explore the mechanisms 
of occurrence and development of brain tumor and promote clinical research. From past to 
future, the far-sighted men attached and will continue to attach importance to the 
development of animal models of human gliomas. Judging from the research and 
development process, human beings have, after a hundred years’ efforts, moved from the 
development and application of animal models of spontaneous and induced brain tumor to 
the generation of the experimental platform of various animal models of human brain 
tumors. Now we are trying to improve the simulation of the animal models to the human 
diseases. For the human glioma, the early model was the solid tumors formed by directly 
inoculating in vitro passaged cell lines to animals; then, human glioma tissue were 
successfully inoculated into animals. In recent years, with the progress of tumor molecular 
biology, transgenic or gene knockout procedures are used to generate genetic engineering 
mouse brain tumor model, which meet the requirement of finding the molecular etiology of 
human brain tumors through specific molecular genetics. After the successful cloning of 
glioma stem cells, the establishment of animal models retaining the characteristics of glioma 
stem cells is on the agenda. In short, although we face difficulty building up animal models 
of brain tumor, we have tried to imitate the models to diseases from the system-cell level to 
the system-cells -molecular level. 
2. The types of tumor model 
2.1 Allogeneic graft model of mouse brain tumor 
Although allogeneic grafting of animals’ spontaneous tumors succeeded before, this method 
had been abandoned because of its poor simulation such as the low incidence, the early 
stage occult and short survival period of tumor-bearing animals. It has been replaced by the 
development of induced animal brain tumor model. The most commonly used cancer-
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inducing methods are by chemical carcinogen or by viruses. Back to 1939, Seligman et al 
reported that implantation the pill made of the polycyclic aromatic hydrocarbons 
methylcholanthrene in mice brain induced glioma and sarcoma. From the middle of last 
century, the systemic administration of pro-nerve alkylating agent was proved to induce 
nervous system tumors. Since then, the polycyclic aromatic hydrocarbons-induced method 
has been gradually replaced by nitrosourea derivatives-induced methods, especially by the 
methods using nitrosourea and ethyl nitrosourea which have higher rates of inducing 
central nervous system tumors. Nitrosourea can induce tumor effectively in adult mice. It 
can induce astrocytoma, oligodendrocytes, ependymal tumor or the most commonly 
glioma, which is the mixture of all the previous tumor cell types. The intravenous injection 
of ethyl nitrosourea to the 20 days pregnant rats induced the central nervous system tumors 
in all the offsprings. The widely used P494, C6, 9L and G422 animal glioma models are all 
produced by the similar methods. The sensitivity to carcinogen of rat central nervous system 
is formed 10 days before birth, and reaches the peak at birth (50 times sensitize than the 
adult). One month after birth, the sensitivity drops to the adult level. 
In addition to the chemical carcinogen, oncogenic virus is also used to induce gliomas. The 
virus can induce two types of brain tumors: RNA viruses, such as Rous sarcoma virus or 
DNA viruses, such as adenovirus. Concentrated Rous sarcoma virus (0.01ml) have been 
injected into the brains of newborn dogs, which all had gliomas after a period of latency. 
(Bigner et al, 1970) It was also reported that direct injection of AD12 virus into the brain of 
mouse that had been born for 24 hours induced brain tumors after an incubation period of 
several months, most of which are medulloblastoma. Usually for the newborn rats, tumor is 
formed 9-100 days after birth, the longest one takes about a year to mature after viral 
transfection. Tumor cells were implanted by intracerebral inoculation of 4 X 107 chick 
embryo fibroblasts infected with the Schmidt-Ruppin strain of Rous sarcoma virus (RSV). 
With a 15 to 67 day latency, brain tumors were induced in 11 (73.3%) of 15 RSV-inoculated 
monkeys. (Tabuchi et al, 1985) Scientist also found that inoculating the viruses isolated from 
brain tissue of progressive multifocal leukoencephalopathy (PML) patients into hamsters’ or 
monkeys’ brains could induce cerebellum medulloblastoma, hypothalamic gliomas, 
pinealomas, intraventricular ependymoma and many other types of brain tumors in various 
locations. Brain tumors caused by viruses can only be produced into models with stable 
biological characteristics by cloning, such as the RT2 glioma model induced by the chicken 
tumor virus. 
These chemical carcinogens and oncogenic viruses are prevalent in the human environment, 
which which imitates the natural occurrence of spontaneous human gliomas. The induced 
tumors in animals will be continuously passed through generations and the biological 
characteristics of tumors are relatively stable, which play active roles in understanding the 
tumor development and in preventing tumors. However, animal models of brain tumors 
induced by oncogenic have different cycles and different pathological types. Compared to 
human brain tumors, the induced brain tumors in animals were different in genetics, cell 
biology and histology. Researchers hope to develop the xenograft model of human brain 
tumor to improve the simulation. 
2.2 Xenograft model of human brain tumor 
2.2.1 Animal strains 
Typically, it is impossible for the human tumors to grow in the animal due to strong immune 
rejection. So the tumor is usually inoculated in the anterior chamber or parts of the hamster 
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cheek pouch where immune cells can not reach. But these tumors have very unstable 
biological characteristics such as spontaneous regression, so the above method is only used for 
tumorigenicity testing. We have injected immunosuppressive agents dexamethasone in 
newborn rats to successfully inoculate the human glioma cell line SHG44 into the brain of 
Westar rats, which is the first experiment to use human glioma cells for in situ animal 
tumorigenicity experiments. Later, due to the appearance and wide usage of immune-deficient 
animals, the injection methods of immunosuppressive agents have been abandoned. 
Internationally, there are more than 30 kinds of pure T cell deficient nude mice with clear 
genetic background available, as well as T cells and B cells combined deficient mice -- 
(Lasat), SCID (severe combined immunodeficiency), NOD-SCID, CBA / I mice, and Beige 
mice with T cells and NK cells double deficiencies.  The nude mice currently used in China -
- Balb / C, Swiss, and NC strains -- were imported from abroad in the early 80s of last 
century. The NC strain mice introduced from Japan in 1981 are non-inbred nude mice with  
high reproductive rate; they are resistant to pathogens and easy to manage. They are still 
used for establishing human glioma models NHG-1. 
The recent established green fluorescent protein (GFP) transgenic mice C57BL/6J-GFP are 
very popular because it is easy to trace the green fluorescence in the host tissue or cells of 
tumor xenograft models. However, tumor xenografts could not be established because of 
their normal immune function. To apply them in human cancer model transplantation, Yang 
and colleagues (Yang et al, 2004) successful hybridized them with nude mice to produce 
immunocompromised nude mice expressing GFP which are suitable for human cancer 
transplantation. We have also successfully cultured the NC nude mice expressing GFP 
(Figure 1), and these mice have been used in human glioma xenograft experiment.  
2.2.2 Method of transplantation 
Commonly, tumor cell lines cultured in vitro, tumor tissue or the cell suspension digested 
from tumor tissue are used for eatablish xenograft model. Usually, the implantation sites 
can be subcutaneous space, foot, abdomen, renal capsule, intracranial brain parenchyma, 
ventricles or spinal subarachnoid space, depending on the experimental need. In the early 
stage, we established the NHG-1 solid tumor subcutaneously in nude mice model using the 
human brain malignant astrocytic tumor cell lines implantation, the NHE-2 nude mice 
xenograft model using human ependymoblastoma tissue implantation and the mouse - 
human chimeric immune mice model of human glioma using human peripheral blood 
mononuclear cells SCID transfusion. By subcutaneous xenograft, it is not only convenient to 
observe the tumor volume by visual or dynamic measurement, but also easy to evaluate the 
effects of anticancer drugs. However, the tumor formed in this way is not in the brain and 
the blood-brain barrier, the macro- and micro- environment of tumor cells are quite different 
from those in clinical diseases. Therefore, the orthotopic transplantation model of human 
brain glioma in nude mice is a better model for imitating the clinical diseases. 
The animal model of glioma orthotopic transplantation used in previous researches usually 
applied cell suspension cranial injection or tissue inoculation with craniotomy (Antunes L et 
al, 2000, Bradley NJ et al, 1978, DeArmond SJ et al, 1994, Horten BC et al, 1981, Rana MW et 
al, 1977, Taillandier L et al, 2003).  The former method can be used to generate the tumor 
model, but the procedure is too complicated. There are lots of issues, for example: (1) the 
tumor cells for inoculation are usually cultured in vitro for several generations, which are 
damaged during the trypsin digestion. It is difficult to get enough living cells; (2) the 
injection volume and speed are restricted by automatic pump because of the small 
www.intechopen.com
 Brain Tumors - Current and Emerging Therapeutic Strategies 
 
6 
compensatory volume. It will take a long time to make the model; (3) the inoculation cells 
are out of the incubator for too long to keep all alive because the operation takes too much 
time. Although the same amount of cells was used in different batches of xenograft, it is 
hard to get about the same number of alive cells in every experiment, which have impact on 
the tumor-inducing rate and latency. Although the later method can avoid the above 
problems, there are still lots of concerns such as large craniotomy injury to mice, 
complicated operation and other issues. We used needle for transplanting tumor tissue in 
either subcutaneous or intracerebral space, as shown in Figure 2. In such way, the trauma 
was relatively small. Compared with the cell suspension, tissue transplantation inoculated 
suitable environment (stroma) at the same time. It is better in maintaining the original 
parental tumor structure, tumor biology or molecular phenotype.  
 
 
Fig. 1. The proliferation and fluorescent protein expression in nude mice transfected GFP: A 
row, IVC system, an independent air supply cage for mice, produced in Suzhou, consists of 
4 parts: the air supply system, exhaust system, cage, mouse box. Fan is imported from 
German; high efficiency filter is produced by Aetna, a chinese-Japanese jointed venture; 
differential pressure gauge is imported from the United States. The cage is made of 
imported stainless steel tubes 304. The rat box is made of polysulfone transparent material. 
B row, from left to right are NC male mice used for breeding, neonatal of GFP/C57 female 
mice, bred GFP/C57/NC nude mice and adult mice. C row, from left to right are 
GFP/C57/NC nude mice under anatomy, eye view of mice brains, the cerebral hemispheres 
and bone marrow biopsy under fluorescence microscopy. 
A 
C 
B 
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Fig. 2. The diagram of intracerebral and subcutaneous tumor xenograft transplantation: A-K: 
the surgical instruments, including micro-cranial drill (A), a metal trocar for subcutaneous 
inoculation (B), plastic trocars (C, D) and plastic trocars for intracerebral inoculation (E, F). 
For intracerebral inoculation, an external pin 2mm or 3mm shorter than the inner sleeve of 
the jacket tube (F, white arrow) must be used to control the depth of the puncture (if 
necessary, use the caliper G for measurement). Use the forceps to move the tumor tissue (I) 
on the top of the trocar (J, arrow), then use propeller (H) to push the tumor tissue into the 
casing, any extra tissue will overflow automatically from the needle end, and then place the 
core needle, push ahead to the second stent level (2-3mm length of tumor tissue is still left in 
the casing, at this piont, K). In intracranial inoculation, the anesthetized animals should have 
scalp incision, and drilled at 2.5mm right to the sagittal suture, 1.0mm to the cranial coronal 
suture (L), the needle to be vertically inserted into the brain (2mm or 3mm) and the inner 
core is pushed slowly until the tumor tissue be removed from the casing into the caudate 
nucleus (M, N arrow). If the tissue need to be inoculated subcutaneously in the puncture site 
(usually in the right armpit), use ordinary needle to puncture a hole, and then put the metal 
casing filled with tumor tissue (P) in the puncture holes, push the core of the casing to move 
the tumor tissue into the subcutaneous (O), slowly remove the needle. Plastic trocar also can 
be used for inoculation (Q). 
There are essential indicators for evaluating the inoculation quality: transplantation success 
rate and the stability of parent tumor characteristics. According to the author's experience, 
the success rate of brain tumor xenografts is determined by the following factors. (1) For the 
subcutaneous inoculation, the nearer the location is to the head, the easier it is to generate 
the model. (2) Compared with using human tumor tissue, it is easy to generate the model by 
using the established tumor cell lines. The in vitro cultured tumor cell lines have stable 
A B C
G 
H
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K 
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D E F
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biological characteristics and proliferate very fast, which make it ideal for establishing 
xenograft model. The tumor tissue inoculation keeps the original tumor characteristics in 
simulating the blood supply, interstitial structure and growth characteristics. (3) It is more 
successful to use tumor tissue inoculation than using trypsin digested tumor cells 
inoculation. The latter method can provide the exact amount of inoculation cells. (4) The 
more cells inoculated, the shorter the incubation period would be (no less than 1 × 107 cells 
in the initial inoculation). But Singh's group (Singh et al, 2003, 2004) has reported that it was 
the number of tumorigenic stem cells, rather than the number of total cells, that has decisive 
effect. The study also showed that 102 tumorigenic stem cells are sufficient for tumor 
generation, while 105 non-tumorigenic stem cells would not. (5) Compared with inoculating 
in subcutaneous space and in the abdominal cavity, it is easier to generate the model by 
inoculating in the peri-renal adipose capsule with relatively low immunity or in 
intracerebral space. 
To determine the stability of transplantation tumor biologic characteristics, the models must 
be evaluated by the following indicators: (1) maintain the genetic characteristics: the 
chromosome of transplanted tissue is same as the primary inoculated human tumor tissues; 
(2) maintain the morphological features: the morphology, mitotic status, tumor stroma and 
vascular structures of transplanted tissue are identical to the primary inoculated human 
tumor tissues under the light and electron microscopy; (3) maintain the tumor markers: the 
specific qualitative biochemical indicators or quantitative biochemical indicators of 
transplanted tumor tissues are consistent with those of  the primary inoculated human 
tumor tissues; (4) maintain the stability of the biological characteristics of tumor-bearing 
animals: after several generations, when the transplant success rate reaches 100%, there are 
less difference in spontaneous regression, tumor size and the survival rate between tumor-
bearing animals; (5) maintain the proliferation kinetics of tumor cells: the mitotic index, 
phase, cell cycle and doubling time are almost the same. According to the above criteria, we 
have successfully established a primary malignant glioma and lung cancer brain metastases 
orthotopic transplantation nude mice models. 
With the progress in the cancer stem cell research, it seems the quality control of animal 
models should be focused on the probability of replicating the parent tumor stemness 
characteristics. As is mentioned above (Singh et al, 2003, 2004), Singh’s group found that 
there are inconsistent cellular renewal and proliferation rate in human brain tumors.  They 
have isolated CD133+ tumor stem cell, the only subtype that can cause intracranial tumors, 
and proved that CD133+ cells are the tumorgenic cells in human brain. These findings make 
the generation of stem cell-induced brain tumor animal model possible. XioNan Li's group 
had generated the real animal models using human brain stem cells (Shu et al, 2008). 17 
cases of pediatric glioma specimens were grounded into single cells or 3-5 cells suspension, 
and were injected into the NOD-SCID mice brain or cerebellum using the needle. He built 10 
animal models for human glioma xenograft. Evaluated by HE staining and the critical 
markers, especially CD133 immunohistochemistry, the transplanted tumor retained the 
parental tumor characteristics, like invasion, histological type and BTSCs and stem cell pool 
expressing CD133 +. In the tumor neovascular, the human specific CD31 and CD34 were 
negative, while the human /mouse shared vWF was positive. The results indicated that the 
tumor neovascular was provided by the host. It is controversial, because previous report 
indicated that BTSCs provide the neovascular. BTSCs originated angiogenesis have been 
found in vitro and in vivo. Our results were different from those of Li’ team, because we used 
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tissue inoculation while Li et al. used single-cell or 3-5 cells cluster inoculation; these two 
methods may provide different micro-environment for BTSCs. We think that tissue 
transplantation will better maintain the characteristics of origin tumor. 
2.3 Genetic engineering model of mouse brain tumor 
In 1984, Brinster et al fused the promoter (MK) with polyomavirus SV40 gene. After enzyme 
digestion, he microinjected the DNA fragments into male pronucleus of fertilized eggs to 
built transgenic mice. The transgenic mice developed a variety of tumors, such as choroid 
plexus papilloma, thymoma and tumors in endocrine system. In 1988, Reynold et al. used 
H-2kb/ SV40 infusion to generate the transgenic mice, which provided results similar to 
Bringster’s. Later, Vogel et al fused HTIV-LTR with tat gene, the injected transgenic mice 
can spontaneously develop neurofibroma. In 1990s, the transgenic glioma model was finally 
generated.  Studies showed that there were lots of similarities between the making of glioma 
model and other tumor models. Some important DNA elements, such as the promoters and 
enhancers, modulated the transfected gene; the foreign genes fused with promoter and 
enhancer promoted a strong expression of target genes. The promoter or enhancer can be 
located in the upper stream or down stream of the genome, or it can be inserted in the non-
transcribed DNA fragments (introns). There are constructed transgenic mice with 
astrocytoma, medulloblastoma, oligodendroglioma and multiforme glioblastoma.  
2.3.1 Genetic engineering mouse of astrocytoma 
Bachoo et al (Bachoo et al, 2002, Xiao  et al, 2002) developed the mouse glioma model using 
retroviral carrying the active EGFR to infect astrocytes. They confirmed that injection of 
Ink4a/Arf-/- astrocytes expressing EGFR formed spheres into the animal's brain induced 
the formation of the high invasive astrocytoma. To simulate the RB mutations, Terry Van 
Dyke et al generated mouse astrocytoma model by introducing SV40T antigen (T121) which 
bind with RB and RB family members, P107 and P130 under the control of glial fibrillary 
acidic protein (GFAP) promoter. In 1995, Andrew Danks et al reported GFAP/SV40 TAg 
transgenic low-grade astrocytoma model. GFAP is the primary marker to identify the origin 
of the tumor, while SV40 TAg binds to P53 and inhibits its activity. After these two proteins 
were combined, the former regulated SV40 TAg and promoted its development of astrocytic 
tumors, while the latter suppressed the activity of wild-type p53 and promoted tumor 
development. As was shown in morphology and immunohistochemistry, astrocytes mainly 
were located in the subependymal zone in GFAP/SV40 TAg transgenic mice. Consistent 
with the characteristics of astrocytomas, some were located in the brain parenchyma or 
around neurons and blood vessel with GFAP expression. Chinese researcher Li HD reported 
that transfection myc andSV40TAg would promote cerebellum neuroblastoma and 
pancreatic cancer development. 
2.3.2 Genetic engineering mouse of oligodendroglioma 
Myelin basic protein (MBP) is an over-expressed protein during the formation of nerve 
myelin, which located in oligodendrocytes in the central nervous system or in Schwann cells 
in the peripheral nerves system. Oncogene neu was highly expressed in the majority of 
gliomas. In 1992, Hayes recombined Neu gene isolated from PSV2neu NT plasmid with 
MBP isolated from Cosmid (cos138) clones, and implanted it into C57BL / 6 × DBA / 2 F2 
fertilized eggs. Of the 93 fertilized eggs injected with the recombined DNA, 14 of them had 
offspring. Four of the neonatal had brain tumors, which appeared in the underside of the 
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brain, the thalamus and the posterior fossa and compressed the brain stem. Under the light 
microscope, the brain tumors of three mice had the characteristic morphology of 
glioblastoma multiforme, and had extensive leptomeningeal invasion. Under the electron 
microscope, there were some characteristics of undifferentiated cells. To identify the origin 
of tumor cells, they used NF, GFAP, MBP and Leu 7 immunohistochemical staining. The 
results showed that there were GFAP, MBP and Leu 7 positive staining in relatively well-
differentiated tumor cells, while in low differentiated tumor cells, less GFAP, MBP, and LEU 
7 positive staining were found. None of the cells had NF positive staining. For the 
morphological analysis, Hayes's experiment did not successfully induce typical 
oligodendrocyte tumor, although the expression of MBP and Leu 7 indicated the presence of 
oligodendrocytes. The hybridization analysis was further used to clarify its origin, the 
results showed that a large number of neu gene presented in tumor cells, but not in normal 
brain cells. In addition, the results also showed that RNA level of myelin specific proteins 
MBP, PLP, MAG and CNP were 5-10 times higher in tumor cells than in the control group, 
which suggested that the myelin-forming cells was enriched in the tumor. There was no 
myelination protein Po found in peripheral nerve, indicating that tumor cells were derived 
from oligodendrocytes, but not from Schwann cells.  Moreover, there was no NF detected in 
brain tumor cells, indicating that there was no neuron present in the tumors. Analyzed by 
the solid tumor markers, Hayes had established the transgenic mice of oligodendrocyte cell 
tumors. 
2.3.3 Genetic engineering mouse of glioblastoma 
Injection of the combination of activated Ras and AKT into an Ntv-a transgenic mice 
induced glioblastoma tumor (Holland et al, 2000). When the DNA mixture was injected into 
Ntv-a mice with inactivate NK4a-ARF, the formation of the glioblastoma was accelerated. 
Ras and Akt work on the downstream signaling pathways of several growth factor 
receptors. In most of the glioblastoma multiforme tumors (GBMs), Ras and Akt are activated 
simultaneously. It has been proved that the abnormal expression of Ras can inhibit p53/RB 
pathway which induced the transformation of astrocytes into anaplastic astrocytoma cells 
that finally obtained GBMs characteristics after transfection AKT in the cells. These results 
confirmed the combined action of Ras and AKT in malignant glioma. Another GBMs model 
is generated in Nf1 and p53 double-silent mouse mated by the p53 knockout mice and the 
heterozygous of Nf1 and Cis (Reilly et al, 2000). Transplantation cells from such mice into 
other mice induced glioma or GBMs, which was caused by a depletion of a tumor 
suppressor gene instead of overexpression oncogene. Despite the molecular differences in 
previous GBMs models, they have something in common. Nf1 (nerve fiber) suppresses Ras 
activity, Nf1 knockout would lead to RAS activation. Nf1 alone is not sufficient to induce 
tumor formation, Nf1 combined with p53 deletion or lack of cell cycle regulation will induce 
tumor formation. 
2.3.4 Genetic engineering mouse of medulloblastoma 
Generation of Ptch heterozygous mice is essential for the development of medulloblastoma 
transgenic mouse model. It is well known that Ptch receptor suppress proliferation through 
SHH / GLI signaling pathway. Inactivated Ptch receptor increases the risk for 
medulloblastoma, about 14% to 19% of the Ptch +/- mice develop medulloblastoma within 
12 months, indicating that retained Ptch locus still function.  When these mice were mated 
with the p53 deficient mice, the tumor incidence of their offspring increase to 95%, all 
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affected mice die within 12 weeks (Zurawel et al, 2000, Wetmore, 2001), suggesting that P53 
plays an important role in this model.  
The systemic experiment on the retroviral model and RCAS/tv-a indicated that SHH 
pathway was related to the formation of medulloblastoma. Under the guidance of 
ultrasound, utero injection of retroviral SHH directly into the cerebellum could induce 
medulloblastoma (Weiner et al, 2002). Fults et al over-expressed SHH in newborn mouse 
cerebellum using RCAS / tv-a system, which induced the formation of medulloblastoma. c-
Myc over-expression enhanced the induction. SHH's activities require the participation of 
Ptch. Inactivation of p53 and RB genes in neural progenitor cells in cerebellar granule cell 
layer developed brain tumor, indicating that RB family proteins may work on the 
tumorgenesis.  P53 and RB conditional knockout mouse can produce a medulloblastoma, 
while single inactivated p53 or RB genes has no such effect. Some studies have shown (Tong 
et al, 2001) that adenosine diphosphate ribose polymerase (ADRP) is an early DNA damage 
response molecule.  The mouse lack of ADP-ribose polymerase mate with the p53 gene 
deficient mice to generate ADRP and p53 double deletion mouse. Half of the mice have 
medulloblastoma located in the cerebellum. 
3. Pathological features of transplantation tumor 
When human cancer tissue or cells are transplanted into animals, the micro-ecological 
environment has undergone tremendous changes. The cell morphology, molecular biology, 
host survival period, clinical symptoms of tumor are difficult to keep consistent with those 
of original tumors in many ways. Tumors developed with single cell suspension or ectopic 
transplantation have the interstitial and vascular components provided by the host (mouse), 
which is significantly different from clinical disease. For example, in human glioma 
subcutaneous xenografts model, the tumor weight up to 5-6 grams is not life-threatening to 
the 25 grams weighted nude mice. For the intracranial tumor, even when the inoculated 
tumors cover the entire cerebral hemisphere, or grow into the contralateral hemisphere, the 
cranial tumor-bearing mice are still alive (Figure 3). Therefore, to study the pathology of 
transplant tumor, we have to link them with clinical as closely as possible. There is no much 
references available, so we shared a few research data with all the readers here. 
3.1 Homogeneity 
Xenografts inoculated in nude mice can induce the transplant tumor having pathological 
features similar to the clinical specimens. Usually, the subcutaneous xenografts in nude mice 
are different from the original tumor. Brain glioblastoma multiforme tumor (GBM) 
transplanted subcutaneously in nude mice does not have the typical GBM features, but 
more like "fibrosarcoma". When the xenograft is inoculated in the brain, some invasive 
characteristics and molecular markers are consistent with the parental tumor. Our data 
proved that the parental tumor is non-invasive and overexpression of CEA, with acidic 
mucus secretion, the brain tumor metastases from lung cancer in nude mice can mimic these 
characteristics. While the highly invasive GBM with high expression of EGFR inoculated 
into nude mice brain showed highly invasive and EGFR over-expression characteristics. For 
morphology analysis, it is rarely identical. The morphology of implanted tumor has 
different characteristics depending on different locations, such as cerebral cortex, white 
matter, gray matter, ventricles and cerebellum.  
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Fig. 3. NC glioma in nude mice, SCID mice transplanted subcutaneously, dexamethasone 
immunosuppressed Wistar rats and brain transplantation model in Balbc nude mice: the 
cells in subcutaneous space and in brain grow into large tumors due to unlimited 
proliferation. Intracranial skull uplifting can be observed in some mice (C, D black circle). 
Observed with cranial dissecting microscope or bear eye, the transplanted tumors almost 
covered the entire hemisphere (C arrow), or reached the olfactory lobe and the contralateral 
frontal lobe (D arrow). If spread to the choroid plexus, the tumor will cause hydrocephalus, 
both hemispheres are highly swollen (E) and ventricular expansion (F) will be noticed. 
3.2 Mimesis 
In the tissue repair process involving neural stem cells, the amplified daughter cells must 
have the same type of repair tissue to rebuild the function of cells, a phenomenon known as 
mimesis of neural stem cells, which had already been confirmed. We only focus on what the 
xenograft grows like and the tissue types of the parental tumor. When the glioma stem cells 
were implanted, we only checked whether the xenograft had neurons and glial cells 
features, rather than clarifying the subtype of the tissue. Our experiments have shown that 
stem cells derived from GBM grew diffusely, when it is located in the choroid plexus, it 
developed into choroid plexus carcinoma (Jun et al, 2010); when it settled in the ventricle 
wall, it developed into the ependymal neuroblastoma; when it settled in the brain surface 
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and spinal table, it developed into uniform small round cells (do not know the subtype). In 
short, stem cells derived from GBM implantation has no typical GBM characteristics, the 
type of transplant tumor highly depends on the location. We believe that glioma stem cells, 
like neural stem cells, have mimesis growing characteristics.  
3.3 Remodeling 
The tissue remodeling during the development is very common. In tumor development and 
progression, it is not conclusive whether there is remodeling between tumor and the host 
tissue cells, such as interstitial and vascular. Tumor vessel remodeling was first discovered 
in the malignant retina melanoma and the xenograft (Maniotis et al, 1999, Zhang et al, 2006). 
The vessels composed of tumor cells are called vessel memisis; while the vessels composed 
of tumor cells and endothelial cells are called mosaic blood vessels. We have made detailed 
observation on tumor vessel in malignant glioma (Yue et al, 2005).  In human glioma 
transplanting into nude mice, the glioma stem cells migrated and proliferated around the 
host blood vessels.  Besides relying on the host for the blood supplies, the tumor had 
spontaneous vascular memisis and mosaic blood vessels to provide nutrition for rapidly 
proliferating tumor. Moreover, some vascular wall cells had both host protein and tumor 
protein expression, indicating that in the process of tumor angiogenesis, the tumor stem 
cells as well as tumor-derived endothelial cells were directly involved.  
There are several types of cancer stem cells and host cells remodeling.  Besides the vascular 
remodeling, it is possible that the individual suspension glioma stem cells could remodel 
with host cells. There are following possibilities: (1) individual tumor cell relies on the host 
stromal cells for nutrition supply, therefore remodeling with the host vessel; (2) individual 
tumor cells fuse with host cells or other tumor cells to form multinucleated giant cells or 
aneuploid cells, which use the fusion cells to rebuild tumor blood vessels; (3) in very few 
cases, individual tumor cells, in particular disseminated tumor cells, transdifferentiate into 
vascular endothelial cells and build stem cell niche (Niche), which expand to form a distal 
distribution of tumor cells block. With the tumor progression, the host tissue gradually 
disappears among tumor mass.  
3.4 Tumor imaging  
The earlier imaging study about the animals bearing human brain tumor used single photon 
emission computed tomography (PET). Using tumor monoclonal antibody labeled with 
iodine radionuclides, the biological imaging of subcutaneous tumor had been collected by 
the γ camera and SPECT (single photon emission computer-aided tomography) machine in 
tumor-bearing mice, which may guide the diagnosis (Haubner  et al, 2001, Herschman  et al, 
2003 Massoud & Gambhir, 2003,). 18F Radionuclide labeled glucose associated with tumor 
cell metabolism is also been used to trace tumor proliferation activity. Since most of the 
tumor-bearing animals are rats or mice, inoculated brain tumors are difficult to distinguish, 
both methods only work for the subcutaneous tumors. With the improvement in scientific 
technology, foreign researchers have used animal-specific high magnetic field MR (3-17.6T) 
on rats or mice for conducting imaging studies of intracranial tumors (Beck et al, 2002, Lewis 
et al, 2002, Pirko et al, 2005). Chinese researchers are still using ordinary field MR (1.5T) for 
imaging studies of rat intracranial tumors. Recently, we used rats and mice specific small 
coil 1.5T MR machine for imaging studies of orthotopic glioma in nude mice. We got some 
satisfactory results, which can be used for monitoring tumor and adjacent structures and 
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calculating tumor volume. But it will take a long imaging time and can not mimic the 
patient pictures. 
Tumor vessel imaging is part of the tumor imaging. Percutaneous transcatheter and 
intravascular injection of contrast agents, and digital subtraction angiography (DSA) are 
used to get tumor microvascular data. However, the transplanted tumors mostly use small 
rodent animals, on which the DSA technology can not be applied. The vascular endothelial 
cell marker, such as CD34 + was used to calculate the vascular density and evaluate the 
number of tumor blood vessels, and the therapeutic effect of anti-tumor angiogenesis drugs. 
However, this method can not be used to evaluate the transporting function of these vessels. 
The cancer stem cell self-generated blood vessels (vasculogenesis) different from the host 
vascular endothelial cells formed blood vessels (angiogenesis). We established the activated 
carbon granular heart chamber perfusion method, which confirmed that various types of 
tumor vessels are involved in tumor-bearing animal systemic circulation (Figure 4) (Dong et 
al, 2010). The detailed procedures are as following: (1) producing activated carbon 
suspension: activated carbon particles were ground into powder and added to the PBS to 
make the suspension. Then the mixture was filtered through 40-micron net (U.S. BD 
Company). After rested for 1 min, the carbon particle was sucked by a flat cut, polished 
needle; (2) infusing activated carbon suspension: the tumor-bearing mice were anesthetized 
by 10% chloral hydrate. The syringe was pierced through the left ventricle of mice, while a 
small hole was cut in the right atrial appendage of the heart to facilitate the replacement of 
circulating blood. After 2-3 ml of carbon suspension was infused, the tumor tissue was 
removed, fixed in 4% paraformaldehyde and embedded in paraffin; (3) analyzing the 
perfusion results: active carbon particle suspension in left ventricular cavity went into host 
circulation and the tumor blood circulation. The active carbon particle distribution was 
related to the blood density. There were small carbon particles in host large vessels and new 
bleeding necrotic area, and integrated condensate active carbon particles in the medium-
sized blood vessels, aggregated carbon particles in the tumor microvascular. It is worthy to 
mention that the active carbon particles would leak out of the lumen because the carbon 
particle is less than 40 microns in diameter, smaller than the red blood cells. It is interesting 
that the carbon particles were present in the marker of highly malignant tumor "false daisy 
group" and "tumor necrosis". For the former one, few carbon particles were observed in the 
central lumen, while in the latter structure, large piece of carbon particles were scattered in 
the gap of sparse distributed tumor cells. Since there is no red blood cells or other tangible 
materials found, suggesting that this change existed after tumor necrosis. The present 
carbon particles indicated that there was nutrition supply, suggesting that necrotic tumors 
tissue might have a micro-environment promoting "self-healing" process.  
Imaging of fluorescent protein tracer is a newly developed technology. We had inoculated 
human glioma stem cells SU3 transfected with red fluorescent protein (RFP) into BAlbc 
nude mice brains to trace its location (Fig. 5). Hoffman (Hoffman, 2002) had inoculated U87 
glioma cells transfected with RFP into the brains of nude mice expressing green fluorescent 
protein (GFP). Farin et al (Farin et al, 2006) had injected C6 glioma cells labeled with eGFP 
and DsRed-2 into the forebrains of neonatal rats, and used fluorescence imaging to observe 
dynamic tumor growth in vivo. Although clarity of the imaging, precision of the display of 
tumor size, location and depth are still not satisfying, this method will be widely used with 
the development of technology. In this platform, the outstanding finding was that glioma 
cells invaded brain tissue along the cavity of blood vessels. Tumor cell intruded into the 
endothelial cells and the pseudo foot of astrocytes, not the vascular cavity. In addition, 
glioma cells jumped forward sometimes slowly and sometimes rapidly, with the maximum  
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Fig. 4. Carbon particles ventricular perfusion in tumor-bearing mice, to trace blood flow of 
new Integrated tumor vessels. When carbon particles are perfused in tumor-bearing mice 
hearts, the blood flow of new tumor vessels is showed as following: A: suspension of carbon 
particles by light microscopy; B: the ventral surface profile of brain tumor, showing the 
basilar artery and Willis ring filled with carbon particles; C-K: the HE sections, showing that 
the carbon particles go into the following vascular tissue: subarachnoid space (C); choroid 
plexus (D); normal brain tissue (E); tumor margin (F); tumor foci (G); massive tumor tissue, 
including some endothelial-dependent blood vessels (H, host blood vessels) and some blood 
vessels formed by tumor cells (I, vascular mimesis); carbon particles leaking from tumor-
origin blood vessels (J, arrow in magnified square); carbon particles in the central vessel of 
false daisy (K, circle); besides, carbon particles existing outside of vessels in the tumor 
necrosis, in acute necrotizing period, carbon particles and floating red blood cells coexist 
(M); after the acute period, carbon particles exist in absorbed lesions (N), indicating that 
there are blood supply even in the repair period of tumor necrosis. 
speed over 100um per second; the migrated cells would go through proliferation and 
division. Cells divided at or near the vascular bifurcation. This was the first time the 
comprehensive kinetic data about glioma cell infiltration in vivo was recorded, which 
indicated that the proliferation and migration of glioma cells related closely with host 
vascular system. Considering from the reconstruction of tumor tissue, host's own tissues 
and cells also play an important role and provide nutrition for the growth of tumor. Yang 
(Yang et al, 2004) and we had inoculated human glioma stem cells non-transfected and 
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transfected with RFP into nude mice brains. The former model (Jun et al, 2010) had proved 
that cancer stem cells involved in tumor blood vessel formation and fusion with host cells; 
In the latter model, host cells were proliferating actively around the tumor, and active host 
cells cultured in vitro have immortalized features (Figure 6). 
 
 
Fig. 5. Tracing human glioma stem cells SU3 and orthotopic transplantation tumor in Balbc 
nude mice with red fluorescent protein (RFP)mice: A and B: the SU3 with RFP transfection 
cultured with growth factors or serum under optical phase contrast microscope; C and D: 
the brain tumor observed in natural light and excitation light, red swollen tumor in th front 
of the brain; E and F: the tumor tissue sections under confocal microscope, the red tumor 
cells (E) and the nuclear staining (F) crowdedly arranged, suggesting a high degree of 
malignancy. 
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Fig. 6. The image of RFP / GFP brain tumor biopsy under fluorescence scanning confocal 
microscopy. RFP/GFP brain tumor biopsy under fluorescence scanning confocal microscope 
(A), human glioma stem cells (SU3) transfectded with RFP is red, host (NC/C57BL/6J-GFP 
nude mice transfected with GFP) tissues and cells is green, the nucleus is blue. There are 
host tissues in tumor interstitial and around the active zone, where the high proliferative 
host cells crowed together. The morphology are diverse among the cell suspension cultured 
from the tissue taken from the active zone under the the fluorescent microscope. Some of 
them are pleomorphic tumor cells, with several features: star shape, highly proliferative, 
rapidly covering the culture bottom, monoclonal passaged (B); others are macrophages with 
putiplnucleus (C); neurons (D) and fiberblast (E). 
The establishment of fluorescent protein transfected tumor cells and transgenic mouse 
tumor model has made a significant contribution to the medical research. There are lots of 
application followed by pitfalls: (1) although fluorescent protein is less toxic to cells, it has 
cytotoxic effects to liver, heart and nervous stem cells (Huang et al, 2000]; (2) tumor cells 
expressing fluorescent protein may be engulfed by phagocytic cells invaded into the tumor 
area, it is impossible to distinguish them using current technology, which may lead to a false 
judgment of the experimental results; (3) limited by the current technology, the method can 
not fully meet the needs of interpreting fluorescent tracer image. However, we have every 
reason to believe that with the introduction of new imaging technologies, fluorescent tractor 
will make greater contribution to cancer research. For example, neural stem cells and cancer 
stem cells transfected with different colors of fluorescent protein are likely to help 
distinguish the origin of tumor cells; in the tumor micro-ecology research, the improved 
C 
A 
E
B 
D 
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technology will help to dissect the components of cancer stem cell niche; in tumor evolution, 
it is known that anaplastic cell is the basis for malignant tumor, tumor cells and host cells 
transfected with different colors will help to elucidate whether cell fusion could contribute 
to the malignant progression. Finally, during the reconstruction process of transplant tumor, 
the donor and receptor with different fluorescent proteins are expected to be used to record 
their roles non-invasively. 
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